Neuropsychiatric behaviours occur frequently in Alzheimer's disease and other dementias and are thought to arise from the neurodegenerative process. However, it is unclear whether neurodegenerative changes in the hippocampus are associated with neuropsychiatric behaviours such as aggression. In this study, semiquantitative measurements of cell loss, atrophy, neuritic plaque and neurofibrillary tangle load in the postmortem hippocampus were taken for dementia patients, prospectively assessed for neuropsychiatric behaviours. It was found that increased tangle load, but not other hippocampal neuropathological variables, was associated with increased severity of aggressive behaviours and presence of chronic aggression. This study suggests a pathogenic link between neurofibrillary tangle load and aggressive behaviours in the hippocampus of dementia patients.
Introduction
In addition to cognitive impairments, people with Alzheimer's disease and other dementias also frequently exhibit noncognitive, neuropsychiatric behaviours including aggression, depression, overactivity and psychosis [1, 2] . Together, these behavioural and psychological signs and symptoms of dementia (BPSDs) [3] contribute disproportionately to caregiver distress and cost of care associated with institutionalisation [4, 5] . Of the BPSDs identified by instruments such as the Present Behavioural Examination [6] , aggressive behaviours and overactivity are particularly prevalent, occurring in 40-60% of patients [2, 7] . Although another well-established instrument (the Neuropsychiatric Inventory) uses the terms 'agitation' and 'aberrant motor behaviour' [8] , operationally they seem to refer to the same spectra of behaviours [6, 8] . There is mounting evidence that BPSDs are a consequence of the neurodegenerative process, which includes intercellular neuritic plaques (NP), intracellular neurofibrillary tangles (NFT), neurovascular changes and cortical atrophy suggestive of extensive neuronal loss and associated neurochemical perturbations [9] . For example, earlier clinicopathological studies have correlated tangle load in the frontal cortex with agitation and aberrant motor behaviour [10] , whereas disturbances of neocortical cholinergic and serotonergic neurotransmission have been implicated in aggression and overactivity [11, 12] . However, it is not known whether other brain regions are involved in the occurrence of these BPSDs. It is also unclear whether the neuropathological changes reported earlier in BPSDs are specific pathological correlates of behaviours or are indicators of more generalised neurodegenerative processes.
The hippocampus, along with associated structures in the temporal lobe, is particularly vulnerable to Alzheimer's disease and shows significant pathology even in early stages of disease [9, 13] . In addition to the well-established roles in learning and memory formation, the hippocampus is also known to be involved in aggressive behaviours and trait [14, 15] . It is at present unclear whether the hippocampus plays a part in overactivity. In this study, we measured a range of neuropathological changes in the postmortem hippocampus of a cohort of longitudinally followed-up dementia patients. We then correlated these neuropathological measures with clinical assessments of aggression and overactivity.
Materials and methods
The 27 patients included in this study were from a community-based cohort of patients from Oxfordshire, UK who were recruited into a prospective, longitudinal study of behaviour in dementia [2] , and are now part of the Thomas Willis Oxford Brain Collection. Institutional review board approval for the recruitment and study of patients had been obtained from the Oxford Psychiatric Sector Research. All patients were assessed with the Cambridge Mental Disorders of the Elderly Examination Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (www.neuroreport.com).
[16] at study entry and fulfilled Diagnostic and Statistical Manual of Mental Disorders (III edition-Revised) [17] criteria for the clinical diagnosis of dementia. The patients were followed up at 4-month intervals from study entry to death by trained personnel on home visits who administered cognitive tests, including the MiniMental State Examination (MMSE) [18] , and the Present Behavioural Examination, a semistructured, caregiver-directed interview, which investigated in detail a range of behavioural changes observed by the caregiver in the 4 weeks preceding the interview [6] . Using factor analyses of the point of entry interview data, three component behaviours have been identified for aggression (physical aggression, verbal aggression, aggressive resistance to intimate care) and overactivity (walking more, aimless walking, trailing and checking) syndromes [19] . To measure the severity of the behavioural syndromes, each component behaviour was scored as 0 = absent, 1 = mild and 2 = severe at each interview and the highest values for a behaviour at any time during the follow-up period were summed to give the corresponding aggression and overactivity factors, which will each have a maximum score of 6. To measure the chronicity of aggressive behaviours and overactivity, the specific behaviours of physical aggression and excessive walking, respectively, were studied at each interview and rated on a seven-point frequency scale (from 0, absent in the last 28 days; 3, occurring in 14 days of the last 28 days; to 6, present every day). A behaviour was considered to be significant if the 4-month ratings showed a minimum of two ratings more than 3 or there was at least one rating more than 3 and two other ratings from 1 to 3 [20] .
At death, informed consent was obtained from the patients' relatives for the removal of brain. One hemisphere was processed for neuropathological examination by fixing in 10% formalin solution. Of the 27 available patients, 21 were neuropathologically confirmed to have Alzheimer's disease by using the Consortium to Establish a Registry for Alzheimer's Disease criteria [21] , whereas three patients were determined to have vascular dementia based on insufficient Alzheimer's disease pathology to meet the Consortium to Establish a Registry for Alzheimer's Disease criteria, together with the presence of a significant cerebrovascular disease causing infarction and diffused white matter pallor. One patient had mixed vascular dementia and Alzheimer's disease, another had an unusual tauopathy, and one had nigral cell loss and evidence of ischaemic hippocampal damage. All patients with Alzheimer's disease were found to be at Braak stages V-VI [13] . For this study, the fixed temporal lobes were sliced into coronal slices of 5 mm, and subsequently embedded in paraffin wax. Then, 10-mm thick sections were cut at the level of the lateral geniculate body and mounted on glass slides for analyses. Semiquantitative assessments of the hippocampal neuropathological markers were carried out blinded to clinical data of the subjects. For NP and NFT, sections were stained with methenamine silver and a modified Palmgren stain and scored in increasing severity (0 = 'none', 1 = 'minimal', 2 = 'moderate', 3 = 'severe'), according to the earlier published methods [20] . The extent of cell loss was also scored between 0 and 3. Two of the cases (Alzheimer's disease and mixed Alzheimer's disease/vascular dementia) had focally severe cell loss with clear indication of microinfarction. These cases were scored 3 for hippocampal cell loss. Lastly, hippocampal atrophy was assessed by a semiquantitative score from 0 to 3 taking into account the relative expansion of the adjacent inferior horn of the ventricle. We also followed-up these scores with measurement of the lateral hippocampal width (in mm) at the level of lateral geniculate body. In three cases (two Alzheimer's disease and one mixed Alzheimer's disease/vascular dementia; all with atrophy scores of '1') the available sections were taken more rostrally than was the usual practice and resulted in sections through the head of the hippocampus with measurements of between 13 and 19 mm. These 'head' measurements of hippocampal width cannot be directly compared with the lateral geniculate body sections and were excluded from analyses of hippocampal atrophy.
The statistics software SPSS for Windows (version 13.0; SPSS Inc., USA) was used for all analyses. Differences in the neuropathological subgroups were examined using parametric or nonparametric tests after checking data for normality using Kolmogorov-Smirnov tests. Subgroups in which the data were normally distributed, analysis of variance with Least Significant Difference post-hoc tests were used. As behavioural data are nonnormally distributed [11] , the overactivity and aggression factor scores, which measure severity of behaviours, were compared among the neuropathological subgroups based on semiquantitative neuropathological scores using Kruskal-Wallis' analysis of variance by rank. For assessments of chronicity of behaviours, mean neuropathological scores were compared between the groups rated 'absent' and those rated 'present' for a chronic behaviour using Mann-Whitney U-tests. Finally, step-wise multiple regressions were performed to control for concomitant behaviours and neuropathology in individual patients and possible interactions between variables. In all cases, P value less than 0.05 was considered statistically significant.
Results
The demographical and disease variables of the patients and N values for each neuropathological and behavioural rating are listed in Table 1 . Among the patients, none scored '0' for semiquantitative measurements of NFT, NP and cell loss (see figure, Supplemental digital content 1, http://links.lww.com/WNR/A86 for representative hippocampal sections of patients rated NFT = '1', '2' and '3'). Only one individual had a score of '0' for hippocampal atrophy (that is, no observable atrophy). Therefore, the neuropathological subgroups for hippocampal atrophy were designated as '0-1', '2' and '3'. The figure in Supplemental digital content 2, http://links.lww. com/WNR/A87 shows that measurements of hippocampal width correlated well with hippocampal atrophy scores, suggestive of progressive decreases with higher atrophy scores. For intercorrelations among the other neuropathological variables, hippocampal atrophy was negatively correlated with NFT (Spearman r = -0.43, P = 0.028) and positively correlated with hippocampal cell loss (r = 0.59, P = 0.003). NFT was also at the threshold of being significantly correlated with cell loss (r = -0.4, P = 0.054). Of all the neuropathological variables studied, only the highest NFT score of '3' was associated with significantly increased aggression factor scores, whereas overactivity did not seem to be associated with the neuropathological variables (Fig. 1a) . For chronic behavioural assessments, patients rated positive for chronic aggression had higher NFT burden compared with those without chronic aggression, but were unchanged in the other neuropathological variables (Fig. 1b) . Chronic overactivity was not associated with any change in neuropathological variables (Fig. 1b) . Finally, step-wise multiple regression analyses showed that of the variables entered (age, NP, atrophy, cell loss, aggression factor, overactivity factor, disease duration, MMSE at recruitment, MMSE at predeath), aggression factor (b = 0.578, P = 0.007) was the strongest predictor of NFT scores, followed by hippocampal atrophy (b = -0.442, P = 0.031), whereas other variables were excluded from the model.
Discussion
Using longitudinally assessed clinical data and semiquantitative neuropathological measurements, the results of this study broadly support the earlier retrospective studies that showed correlations between NFT load and agitation in the forebrain [10] , and expands upon those findings in a number of ways. First, our data indicate that the brain regions relevant to these clinicopathological associations are not limited to the neocortex, but may also involve limbic areas including the hippocampus. However, we did not find any association between overactivity and hippocampal neuropathology. This suggests that hippocampal dysfunction related to an increased NFT load may affect neurons involved in behaviours of aggression to a higher extent compared with those neurons underlying other behaviours for example overactivity. Furthermore, by studying several neuropathological markers, including NPs, hippocampal atrophy and cell loss, we showed that the increased severity and chronicity of aggressive behaviours were specifically associated with the highest NFT scores. In fact, the negative correlations between hippocampal atrophy/cell loss and NFT suggest that in cases of severe atrophy, NFT-containing cells had disappeared altogether and were no longer detectable. Therefore, in addition to being an indicator of neurodegeneration, our results point to a direct or indirect pathogenic role of NFT in the manifestation of aggressive behaviours in dementia. However, the potential mechanisms are unclear, and several postulates should be considered, including pathophysiological interactions with specific populations of neurons involved in aggressive behaviours (for example, cholinergic and serotonergic), disruption of axonal transport or effects on neurotransmitter function [11, 22, 23] . Alternatively, the association of increased NFT and aggression could be because of a novel factor, (for example, altered glycogen synthase kinase-3b or protein phosphatase-2A function) which could underlie both the neuropathological and behavioural observations [24] . Further studies are needed to delineate and assess these potential pathogenic mechanisms.
Several limitations should be noted in the interpretation of the results of this study. First, by using semiquantitative methods in the evaluation of hippocampal pathology, we are limited to comparing patients under broad categories (for example, 'severe' vs. 'moderate' NFT load), and follow-up investigations using quantitative measurements would be needed. Another limitation of this study is that all neuropathological measurements were taken at the level of the lateral geniculate body. This was necessary to maximise sampling consistency among the patients, but it is unclear whether other regions of the hippocampus would show similar patterns of neuropathological change. Lastly, although the patients included in this study are representatives of the larger cohort from which it was derived [2] , the majority (approximately 78%) of patients were neuropathologically classified as Alzheimer's disease, and Tangles and aggression in dementia Lai et al. 1113 the N of non-Alzheimer's patients (predominantly vascular or mixed dementia) is too small to attempt identification of disease-specific effects. However, this concern is partially mitigated by earlier large-scale studies showing no difference in the prevalence of neuropsychiatric behaviours between Alzheimer's disease and non-Alzheimer's disease dementia [25] .
Conclusion
Our findings suggest a neuropathological link between NFT burden and manifestation of aggressive behaviours, and predict that disease-modifying treatments that result in decreased tangle formation may also lead to amelioration of troublesome BPSDs such as aggressive behaviours or agitation. 
